Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats

Hypertension

Volumn 35, Issue 5, 2000, Pages 1078-1084

  Sun, Yao ^a,b   Zhang, Jiakun ^a   Zhang, John Q ^a   Ramires, Felix J A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Division of Cardiovascular Diseases   (United States)

Author keywords

Angiotensin II; Fibrosis; Growth substances; Kidney; Myofibroblasts; Rats

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; COLLAGEN TYPE 1; CREATININE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME BINDING; ENZYME INHIBITION; GENE EXPRESSION; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY MASS; MALE; MYOFIBROBLAST; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR DENSITY; SYSTOLIC BLOOD PRESSURE; TISSUE DISTRIBUTION;

EID: 0034119204     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.5.1078     Document Type: Article

References (29)

1. Shiota N, Okunishi H, Fukamizu A, Sakonjo H, Hikumori M, Nishimura T. Nakagawa T. Murakami K, Miyazaki M. Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett. 1993; 323:239-242.
2. Anderson S, Jung FF. Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. J Am Physiol. 1993;265:F477-F486.
3. Fabris B, Yamada H, Cubela R, Jackson B, Mendelsohn FAO, Johnston CI. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats. Br J Pharmacol 1990;100:651-655.
4. Daemen MJAP, Smits JFM. The wound healing response after myocardial infarction: structural and pharmacological aspects. In: Weber KT, ed. Wound Healing in Cardiovascular Disease. Armonk NY: Futura; 1995:23-31.
5. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cordiol. 1996;28:851-858.
6. Sun Y, Weber KT. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res. 1996;31:518-525.
7. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27:549-550.
8. Cohen EP. Fibrosis causes progressive kidney failure. Med Hypotheses 1995;45:459-462.
9. Palmer BF. The renal tubule in the progression of chronic renal failure J Invest Med. 1997;45:346-361.
10. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y. Chatani F. Iwao H. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1994;24:195-204.
11. Ishidoya S, Morrissey J, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int. 1996;49:1110-1119.
12. Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindsley J, Bennett WM. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Phvsiol 1995;269: F491-F499.
13. Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy. Kidney Int. 1997;52:660-673.
14. 1, and repair in the infarcted heart. J Mol Cell Cardiol. 1998;30:1559-1569.
15. Menard J, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology. 1971;90:422-430.
16. Larsen K. Creatinine assay by a reaction-kinetic approach. Clin Chem Acta. 1972;41:209-217.
17. Sappino AP, Schürch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest. 1990;63:144-161.
18. Song K, Zhuo J, Allen AM, Paxinos G, Mendelsohn FAO. Angiotensin II receptor subtypes in rat brain and peripheral tissues. Cardiology 1991; 79(suppl 1):45-54.
19. 125I-labelled MK351A. Clin Exp Pharmacol Physiol. 1984;11:431-435.
20. Hall CE, Hall O. Hypertension and hypersalimentation, I: aldosterone hypertension. Lab Invest. 1965;14:285-294.
21. Nagle RB, Bulger RE, Cutler RE, Jervis HR, Benditt EP. Unilateral obstructive nephropathy in the rabbit. I: early morphologic, physiologic, and histochemical changes. Lab Invest. 1973;28:456-467.
22. Zhang G, Moorhead PJ, el Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol. 1995;3: 308-318.
23. Ritz E, Orth SR, Strzelczyk P. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease. J Hypertens. 1997;15(suppl):S21-S26.
24. Sun Y, Ratajska A, Zhou G, Weber KT. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone J Lab Clin Med. 1993;122:395-403.
25. Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodeling in myocardial-infarcted rats. J Mol Cell Cardiol. 1993;25:1369-1380.
26. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
27. Hayashida W, Horiuchi M, Dzau VJ. Intracellular third loop domain of angiotensin II type-2 receptor: role in mediating signal transduction and cellular function. J Biol Chem. 1991;271:21985-21992.
28. Pimentel JL Jr, Sundell CL, Wang S, Kopp JB, Montero A, Martínez-Maldonado M. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy Kidney Int. 1995;48:1233-1246.
29. Kim S, Ohta K, Hamguchi A, Omura T, Yukinura T, Miura K, Inada Y. Wada T. Ishimura Y. Chatani F. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury Kidney Int. 1994;46:1346-1358.